Global Experimental Monkey Market Growth 2026-2032
Description
The global Experimental Monkey market size is predicted to grow from US$ 1267 million in 2025 to US$ 2294 million in 2032; it is expected to grow at a CAGR of 9.5% from 2026 to 2032.
Experimental monkeys, particularly macaques such as Cynomolgus macaques (Macaca fascicularis) and Rhesus monkeys (Macaca mulatta), have long been indispensable models for scientific research. These monkeys are primarily used in the fields of biology, medicine, neuroscience, and drug development due to their close physiological and genetic similarity to humans, particularly in the nervous system. The use of primates as experimental models has played a critical role in advancing our understanding of biological and physiological processes, disease mechanisms, and the development of new medical treatments.
In the upstream supply chain, core raw materials include feed, veterinary drugs, and laboratory supplies critical to the health and adaptability of laboratory primates. Major suppliers in this domain include MP Biomedicals, Yongli Biotech, Beijing Keaoxieli, Pizhou Dongfang, Jiangsu Medicience, and Jiangsu Xietong. These companies play an essential role in maintaining the health standards, traceability, and experimental suitability of monkey populations used in research.
Leading CROs such as JOINN Laboratories, WuXi AppTec, and Envigo (Inotiv) are key end-users in this market. These companies operate large-scale animal research platforms, adhere strictly to animal welfare regulations and ethical review processes, and play a vital role in promoting the standardization and industrialization of experimental monkey supply chains worldwide.
The experimental monkey industry maintains strong gross profit margins, generally ranging from 40% to 60%, supported by the high entry barriers, strict breeding protocols, and value-added services. Customized breeding programs and long-term strategic contracts with CROs or research institutions further enhance profitability across the value chain.
In 2025, global Experimental Monkey production reached approximately 99.89 k units, with an average global market price of around US$ 13 k per unit.
Vanny Bio Research, HZ-Bio, Envigo (Inotiv), WuXi AppTec, and JOINN Laboratories are among the major players in the Experimental Monkey market. The top 10 global players collectively account for approximately 34% of the total market share. These companies play a critical role in supporting the global biopharmaceutical industry by providing high-quality Experimental Monkeys essential for scientific research and drug development.
Among product types, Cynomolgus macaques are the dominant species in the market, accounting for approximately 79% of the global Experimental Monkey usage in 2025. Their broad applicability in toxicology, immunotherapy, and vaccine development, coupled with higher reproductive efficiency and environmental adaptability, makes them the preferred model over Rhesus monkeys and other species. Rhesus monkeys retain strong demand in neurophysiological research due to their cognitive relevance, while other primates are used in niche areas and represent a small portion of the overall market.
On the application side, Contract Research and Development Service Organizations (CROs) are the largest user group of Experimental Monkeys, contributing around 52% of global demand in 2025. CROs support pharmaceutical and biotech clients in preclinical testing, drug screening, and safety assessments, relying heavily on reliable and genetically appropriate animal models. Academic institutions and research centers represent additional key users, conducting fundamental studies and education-based animal research. A smaller proportion of usage is seen in government or public health-related vaccine development programs.
Market growth is driven by rising demand for high-fidelity animal models in cutting-edge drug development areas such as oncology, neurodegeneration, and infectious diseases. The increasing investment in life sciences, coupled with the rapid expansion of CRO capabilities and international collaboration, supports sustained market expansion. However, the industry faces several restraints, including intensifying scrutiny on animal ethics, volatility in global transport and quarantine policies, high operational costs, and the growing sophistication of alternative testing technologies such as organoids and AI-driven screening models, all of which pose potential limitations to long-term market scalability.
LP Information, Inc. (LPI) ' newest research report, the “Experimental Monkey Industry Forecast” looks at past sales and reviews total world Experimental Monkey sales in 2025, providing a comprehensive analysis by region and market sector of projected Experimental Monkey sales for 2026 through 2032. With Experimental Monkey sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Experimental Monkey industry.
This Insight Report provides a comprehensive analysis of the global Experimental Monkey landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Experimental Monkey portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Experimental Monkey market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Experimental Monkey and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Experimental Monkey.
This report presents a comprehensive overview, market shares, and growth opportunities of Experimental Monkey market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Macaca Fascicularis (Cynomolgus Macaque)
Rhesus Monkey (Macaca Mulatta)
Other Types
Segmentation by Age Stage:
Juvenile
Adult
Aged
Segmentation by Sex:
Male Monkeys
Female Monkeys
Segmentation by Application:
Contract Research and Development Service Organization (CRO) Company
Scientific Research Institution
Colleges and Universities
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Vanny Bio Research
HZ-Bio
Envigo (Inotiv)
JOINN LABORATORIES
WuXi AppTec
Jingang Biotech
Charles River
Pharmaron
Xishan Zhongke
ONPRC (Oregon National Primate Research Center)
CNPRC (California National Primate Research Center)
Sichuan Hengshu Bio-Technolog
Topgene Biotechnology
Primate Products, Inc. (PPI)
Sichuan Green-House Biotech
Bioculture Group
Key Questions Addressed in this Report
What is the 10-year outlook for the global Experimental Monkey market?
What factors are driving Experimental Monkey market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Experimental Monkey market opportunities vary by end market size?
How does Experimental Monkey break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Experimental monkeys, particularly macaques such as Cynomolgus macaques (Macaca fascicularis) and Rhesus monkeys (Macaca mulatta), have long been indispensable models for scientific research. These monkeys are primarily used in the fields of biology, medicine, neuroscience, and drug development due to their close physiological and genetic similarity to humans, particularly in the nervous system. The use of primates as experimental models has played a critical role in advancing our understanding of biological and physiological processes, disease mechanisms, and the development of new medical treatments.
In the upstream supply chain, core raw materials include feed, veterinary drugs, and laboratory supplies critical to the health and adaptability of laboratory primates. Major suppliers in this domain include MP Biomedicals, Yongli Biotech, Beijing Keaoxieli, Pizhou Dongfang, Jiangsu Medicience, and Jiangsu Xietong. These companies play an essential role in maintaining the health standards, traceability, and experimental suitability of monkey populations used in research.
Leading CROs such as JOINN Laboratories, WuXi AppTec, and Envigo (Inotiv) are key end-users in this market. These companies operate large-scale animal research platforms, adhere strictly to animal welfare regulations and ethical review processes, and play a vital role in promoting the standardization and industrialization of experimental monkey supply chains worldwide.
The experimental monkey industry maintains strong gross profit margins, generally ranging from 40% to 60%, supported by the high entry barriers, strict breeding protocols, and value-added services. Customized breeding programs and long-term strategic contracts with CROs or research institutions further enhance profitability across the value chain.
In 2025, global Experimental Monkey production reached approximately 99.89 k units, with an average global market price of around US$ 13 k per unit.
Vanny Bio Research, HZ-Bio, Envigo (Inotiv), WuXi AppTec, and JOINN Laboratories are among the major players in the Experimental Monkey market. The top 10 global players collectively account for approximately 34% of the total market share. These companies play a critical role in supporting the global biopharmaceutical industry by providing high-quality Experimental Monkeys essential for scientific research and drug development.
Among product types, Cynomolgus macaques are the dominant species in the market, accounting for approximately 79% of the global Experimental Monkey usage in 2025. Their broad applicability in toxicology, immunotherapy, and vaccine development, coupled with higher reproductive efficiency and environmental adaptability, makes them the preferred model over Rhesus monkeys and other species. Rhesus monkeys retain strong demand in neurophysiological research due to their cognitive relevance, while other primates are used in niche areas and represent a small portion of the overall market.
On the application side, Contract Research and Development Service Organizations (CROs) are the largest user group of Experimental Monkeys, contributing around 52% of global demand in 2025. CROs support pharmaceutical and biotech clients in preclinical testing, drug screening, and safety assessments, relying heavily on reliable and genetically appropriate animal models. Academic institutions and research centers represent additional key users, conducting fundamental studies and education-based animal research. A smaller proportion of usage is seen in government or public health-related vaccine development programs.
Market growth is driven by rising demand for high-fidelity animal models in cutting-edge drug development areas such as oncology, neurodegeneration, and infectious diseases. The increasing investment in life sciences, coupled with the rapid expansion of CRO capabilities and international collaboration, supports sustained market expansion. However, the industry faces several restraints, including intensifying scrutiny on animal ethics, volatility in global transport and quarantine policies, high operational costs, and the growing sophistication of alternative testing technologies such as organoids and AI-driven screening models, all of which pose potential limitations to long-term market scalability.
LP Information, Inc. (LPI) ' newest research report, the “Experimental Monkey Industry Forecast” looks at past sales and reviews total world Experimental Monkey sales in 2025, providing a comprehensive analysis by region and market sector of projected Experimental Monkey sales for 2026 through 2032. With Experimental Monkey sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Experimental Monkey industry.
This Insight Report provides a comprehensive analysis of the global Experimental Monkey landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Experimental Monkey portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Experimental Monkey market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Experimental Monkey and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Experimental Monkey.
This report presents a comprehensive overview, market shares, and growth opportunities of Experimental Monkey market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Macaca Fascicularis (Cynomolgus Macaque)
Rhesus Monkey (Macaca Mulatta)
Other Types
Segmentation by Age Stage:
Juvenile
Adult
Aged
Segmentation by Sex:
Male Monkeys
Female Monkeys
Segmentation by Application:
Contract Research and Development Service Organization (CRO) Company
Scientific Research Institution
Colleges and Universities
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Vanny Bio Research
HZ-Bio
Envigo (Inotiv)
JOINN LABORATORIES
WuXi AppTec
Jingang Biotech
Charles River
Pharmaron
Xishan Zhongke
ONPRC (Oregon National Primate Research Center)
CNPRC (California National Primate Research Center)
Sichuan Hengshu Bio-Technolog
Topgene Biotechnology
Primate Products, Inc. (PPI)
Sichuan Green-House Biotech
Bioculture Group
Key Questions Addressed in this Report
What is the 10-year outlook for the global Experimental Monkey market?
What factors are driving Experimental Monkey market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Experimental Monkey market opportunities vary by end market size?
How does Experimental Monkey break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
135 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Experimental Monkey by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Experimental Monkey by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
